(Q51139733)

30 March 2018

title

Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. (English)

1 reference

30 March 2018

chronic renal insufficiency

1 reference

1 reference

1 reference

Hiroshi Watanabe

1

1 reference

30 March 2018

Hiroaki Obata

2

1 reference

30 March 2018

Toru Watanabe

3

1 reference

30 March 2018

Shigeru Sasaki

4

1 reference

30 March 2018

Kojiro Nagai

5

1 reference

30 March 2018

Yoshifusa Aizawa

6

1 reference

30 March 2018

publication date

1 January 2010

1 reference

30 March 2018

Diabetes - Metabolism: Research and Reviews

published in

1 reference

30 March 2018

volume

26

1 reference

30 March 2018

issue

1

1 reference

30 March 2018

page(s)

26-32

1 reference

30 March 2018

The metabolic syndrome and chronic kidney disease in U.S. adults

cites work

1 reference

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

Projecting the number of patients with end-stage renal disease in the United States to the year 2015

21 January 2018

1 reference

7 January 2021

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes

1 reference

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

7 January 2021

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease

1 reference

7 January 2021

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

1 reference

7 January 2021

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study

1 reference

7 January 2021

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

7 January 2021

The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey

1 reference

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

7 January 2021

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study

1 reference

7 January 2021

Metabolic syndrome and chronic kidney disease in Okinawa, Japan

1 reference

7 January 2021

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

1 reference

7 January 2021

Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study

1 reference

7 January 2021

Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry

1 reference

7 January 2021

Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes

1 reference

7 January 2021

The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort

1 reference

7 January 2021

Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study

1 reference

7 January 2021

New criteria for 'obesity disease' in Japan.

1 reference

7 January 2021

Obesity and the Risk of New-Onset Atrial Fibrillation

1 reference

7 January 2021

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.

1 reference

7 January 2021

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

1 reference

7 January 2021

Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals

1 reference

7 January 2021

Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study

1 reference

7 January 2021

Elevated C-reactive protein levels in overweight and obese adults

1 reference

7 January 2021

Blood pressure and inflammation in apparently healthy men

1 reference

7 January 2021

Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome

1 reference

7 January 2021

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

1 reference

7 January 2021

Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease

1 reference

7 January 2021

Cytokine dysregulation in chronic kidney disease: how can we treat it?

1 reference

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

7 January 2021

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies

1 reference

7 January 2021

Cardiovascular disease and subsequent kidney disease.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1058

1 reference

30 March 2018

1 reference

30 March 2018